Prototype CT Scan for Stroke

(ICH-CTP II Trial)

This trial aims to test two CT scan prototypes, DynaCT Multiphase and DynaCT Sine Spin, to determine if they improve stroke detection and treatment. Researchers will gather CT scans before and after a procedure to assess whether these new tools facilitate spotting brain bleeding and aid in treatment. The trial targets patients scheduled for a minimally invasive procedure to remove brain hemorrhage at Mount Sinai West Hospital. As an unphased trial, it offers patients the chance to contribute to pioneering research that could enhance stroke detection and treatment.

The trial information does not specify whether you need to stop taking your current medications.

Previous studies have shown that the DynaCT Multiphase and DynaCT Sine Spin are safe. Research indicates that the DynaCT Multiphase aids doctors in making better treatment decisions by using 3D images to visualize blood vessels during procedures, potentially reducing the need for additional surgeries. The technology is patient-friendly and non-invasive, which lowers risks.

For DynaCT Sine Spin, studies have demonstrated its accuracy in detecting brain bleeding in stroke patients. This capability allows doctors to see crucial details without resorting to risky procedures. Reports confirm that it provides high-quality images with low radiation, ensuring patient safety.

Unlike traditional CT scans for stroke, which typically provide a single snapshot of blood flow in the brain, the DynaCT Multiphase scan captures multiple images over time. This dynamic imaging can offer a more detailed view of how blood is moving in real-time, potentially leading to faster and more accurate diagnosis of strokes. Researchers are excited about this innovation because it could significantly improve the speed and precision of stroke assessments, making it easier to decide on the best treatment path for patients quickly.

This trial will compare the DynaCT Multiphase scan and the DynaCT Sine Spin scan. Research has shown that the DynaCT Multiphase scan aids in stroke treatment by helping doctors make better decisions through detailed imaging of blood flow in the brain. Studies have found that patients with clearer images of alternative blood flow paths using this scan tend to recover better. In contrast, the DynaCT Sine Spin scan enhances image quality, particularly in critical brain areas. It accurately detects different types of brain bleeds, with a success rate of up to 84.2% for identifying those with the condition and up to 97.3% for those without it. Both scans aim to improve decision-making during emergency stroke situations.²³⁶⁷⁸